NORTH BILLERICA, Mass.--(BUSINESS WIRE)--Nov. 1, 2018--
Holdings, Inc. (the “Company”) (NASDAQ: LNTH), the parent company of Lantheus
Medical Imaging, Inc. (“LMI”), a global leader in the development,
manufacture and commercialization of innovative diagnostic imaging
agents and products, today announced that Company management will
participate in analyst-led fireside chat discussions at the following
- Credit Suisse Securities Healthcare Conference
November 13, 2018 at 4:35 p.m. MT
Robert J. Marshall Jr., Chief
Financial Officer and Treasurer
Location: Scottsdale, AZ
- Jefferies London Healthcare Conference
14, 2018 at 9:20 a.m. GMT
Mary Anne Heino, President and Chief
Location: London, UK
To access a live webcast of the presentation, please visit the Investors
section of the company’s website at www.lantheus.com.
A replay of the webcast will be available on the Company’s website for
30 days following the live presentation.
About Lantheus Holdings, Inc. and Lantheus Medical Imaging, Inc.
Holdings, Inc. is the parent company of LMI, a global leader in the
development, manufacture and commercialization of innovative diagnostic
imaging agents and products. LMI provides a broad portfolio of products,
including the echocardiography contrast agent DEFINITY® Vial
for (Perflutren Lipid Microsphere) Injectable Suspension; TechneLite®
(Technetium Tc99m Generator), a technetium-based generator that provides
the essential medical isotope used in nuclear medicine procedures; and
Xenon (Xenon Xe 133 Gas), an inhaled radiopharmaceutical imaging agent
used to evaluate pulmonary function and for imaging the lungs. The
Company is headquartered in North Billerica, Massachusetts with offices
in Puerto Rico and Canada. For more information, visit www.lantheus.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101006081/en/
Source: Lantheus Holdings, Inc.
Lantheus Holdings, Inc.
Meara Murphy, 978-671-8508
Investor Relations & Corporate Communications